Healthcare industry brief
Tuesday, November 10, 2026 · 133 stories
Operators. Network outage canceled appointments at a New Hampshire hospital, Ballad Health rolled out weapons detection across all its hospitals, and ASC management deals carry cost traps worth reviewing.
Clinicians. Democrats took a new step toward investigating Trump's drug pricing deals, HHS's Vaccine Task Force missed its report deadline, and an early siRNA trial cut liver fat in MASLD patients.
Investors. Labcorp is acquiring Millennium Health for $375M, Ascension and Bon Secours are making multibillion-dollar ASC bets, and Oura bought Counsel for $625M.
Summary lines are written by AI from the day's headlines AI. Interpretation, not reporting. Every story below links to its original source.
Policy and regulation
- CMS allocates 200 Medicare-funded residency slots to 99 teaching hospitalsAHA News, Nov 10, 4:30 PM ETThe Centers for Medicare & Medicaid Services has allocated 200 Medicare-funded residency slots to 99 teaching hospitals.
- STAT+: Wyden, Sanders hand-in-hand on Medicare for All' initiativeSTAT, Nov 10, 3:05 PM ET
- New Medicare Payment Model for Back Pain, Heart Failure Riles DocsMedPage Today, Nov 10, 11:10 AM ET(MedPage Today) -- Physician groups are seeking a delay for a new Medicare demonstration model debuting January 1 that mandates doctors who treat low back pain and congestive heart failure (CHF)...
- Final 2027 Medicare rule cuts GI pay: 5 things to knowBecker's ASC Review, Nov 10, 10:40 AM ETCMS’ final 2027 Medicare payment rules will cut physician payments for GI endoscopy performed in ambulatory surgery centers and hospital outpatient departments by an average of 2%, according to a Nov.
- STAT+: Dutch antitrust regulators probe Biogen over test for its MS drugSTAT, Nov 10, 8:38 AM ET
- Nebraska Rushed Medicaid Work Rules. Then a Cancer Patient Was Told He’d Lost Coverage.KFF Health News, Nov 10, 5:00 AM ETNebraska budgeted $8.2 million for contractors to comply with Medicaid changes under President Donald Trump’s One Big Beautiful Bill Act.
- STAT+: State Democratic wins make Medicaid expansion a possibility for more than a million peopleSTAT, Nov 10, 4:30 AM ET
- HHS Vaccine Task Force Misses Report DeadlineMedPage Today, Nov 10, 5:20 PM ET(MedPage Today) -- Now that the deadline has passed for an HHS vaccine task force to issue its report on the timing and sequencing of vaccines, public health advocates are concerned about what...
- The CJR-X reckoning coming for 2,217 hospitalsBecker's ASC Review, Nov 10, 4:50 PM ETMost hospitals aren’t ready for Medicare’s mandatory joint replacement bundle, according to a Duke surgeon leading his system’s preparation.
- AMA says AI can’t be licensed as a physician, pushes vendor liabilityBecker's Hospital Review, Nov 10, 4:26 PM ETThe American Medical Association has adopted policy saying AI cannot be granted physician licensure, professional titles or certification to practice medicine.
Payers
- Oura's Buys Counsel for $625M, But Will Payers and Consumers Get on Board?MedCity News, Nov 10, 7:12 PM ETOura will be integrating Counsel Health's clinical AI and virtual care into its app, but will payers and employers cover the Oura ring as a benefit?
Health systems and hospitals
- Labcorp acquires Millennium Health for $375MBecker's Hospital Review, Nov 10, 5:32 PM ETBurlington, N.C.
- Ascension, Bon Secours make multibillion-dollar bets on ASCsBecker's Hospital Review, Nov 10, 5:26 PM ETTwo major health systems are making multibillion-dollar investments in ambulatory surgery centers, underscoring a broader industry shift toward outpatient care as more surgical procedures move away...
- Oura to acquire AI primary care company for $625MBecker's Hospital Review, Nov 10, 3:15 PM ETSan Francisco-based wearable technology company Oura has agreed to acquire AI-powered primary care company Counsel Health for $625 million in cash, expanding its business beyond health tracking into...
- STAT+: Oura acquires Counsel Health for $625 million, a big bet on AI careSTAT, Nov 10, 12:14 PM ET
- MaxCyte to acquire cell therapy supplier for $151.8MBecker's Hospital Review, Nov 10, 10:39 AM ETMaxCyte has entered an agreement to acquire Akron Bio for $151.8 million, a deal expected to nearly double its revenue base and expand its cell therapy manufacturing business.
- Hospitals' $132B revenue leakage problemBecker's Hospital Review, Nov 10, 9:29 AM ETU.S.
- Ballad Health launches weapons detection at all hospitalsBecker's Hospital Review, Nov 10, 6:22 PM ETJohnson City, Tenn.-based Ballad Health will begin using weapons detection systems at all of its hospitals Nov.
- New Hampshire hospital cancels appointments due to network outageBecker's Hospital Review, Nov 10, 5:44 PM ETPeterborough, N.H.
- The $14K-a-month catch in an ASC management dealBecker's ASC Review, Nov 10, 5:33 PM ETBefore partnering with a health system, one question would have saved Riverwoods Surgery Center thousands of dollars a month, administrator Adam Shurtz said: What does the fee cover? Mr.
- 22 large health systems ranked by ASCsBecker's Hospital Review, Nov 10, 5:01 PM ETHealth systems are racing to build large ASC portfolios through increasingly high-profile acquisitions. Cincinnati-based Bon Secours Mercy Health plans to acquire Brentwood, Tenn.
Access and care delivery
- Independent physician network collapses amid $15M debtBecker's ASC Review, Nov 10, 5:09 PM ETWaterloo, Iowa-based Cedar Valley Medical Specialists, an independent physician network with more than 20 clinics in northeast Iowa, closed Oct.
- Billings Clinic-Logan Health rebrands as One Sky HealthBecker's Hospital Review, Nov 10, 4:00 PM ETBillings Clinic-Logan Health will now operate as One Sky Health, according to a Nov. 10 news release shared with Becker's.
- Providers underestimate patient comfort with AI by 20 points: GallupBecker's Hospital Review, Nov 10, 12:06 PM ETPrimary care providers underestimate how comfortable patients are with AI making clinical decisions that a provider can change or override, according to a report from the West Health-Gallup Center on...
- Physicians underestimate patient comfort with AI by 20 points: GallupBecker's Hospital Review, Nov 10, 12:06 PM ETPrimary care physicians underestimate how comfortable patients are with AI making clinical decisions that a provider can change or override, according to a Nov.
- Charta Health raises $55M Series B funding ahead of launchBecker's Hospital Review, Nov 10, 12:05 PM ETSan Francisco-based Charta Health raised $55 million in Series B funding for its AI chart review platform, according to a Nov. 10 news release.
- 7 healthcare experts on adopting AI toolsHealthcare Dive, Nov 10, 11:50 AM ETWhen deciding whether to adopt AI tools, it's crucial that healthcare organizations consider governance, clinician trust and overall costs, industry experts said at a Healthcare Dive virtual event...
- Beam’s sickle cell therapy meets primary trial endpointBecker's Hospital Review, Nov 10, 10:46 AM ETBeam Therapeutics’ investigational gene-edited therapy for sickle cell disease met its primary efficacy endpoint in a Phase 1/2 clinical trial, bringing the company closer to a planned FDA submission.
- You're just doing the R D for Epic': Mark Cuban's warning to health tech startupsBecker's Hospital Review, Nov 10, 10:38 AM ETMark Cuban has a test he puts to health tech founders before he backs them, and most of them don't like the answer. The co-founder of Mark Cuban Cost Plus Drug Co.
- Vanderbilt Health restricts IT access amid university cybersecurity incidentBecker's Hospital Review, Nov 10, 10:08 AM ETNashville, Tenn.-based Vanderbilt Health has instructed employees not to access Vanderbilt University’s IT resources as the university responds to an active cybersecurity incident.
- 7 GLP-1 safety concerns clinicians should knowBecker's Hospital Review, Nov 10, 10:06 AM ETThe FDA’s order for a new vision loss warning on GLP-1s adds to a growing list of safety concerns and questions surrounding a drug class now used by millions.
Drugs, devices and trials
- California voters approve $8.4B research bond measure: 5 things to knowBecker's Hospital Review, Nov 10, 11:29 AM ETCalifornia voters have passed Proposition 38, allowing the state to issue $8.4 billion in bonds to fund immunology and immunotherapy research for cancer and chronic diseases Nov.
- STAT+: Democrats take new step toward investigating Trump’s drug pricing dealsSTAT, Nov 10, 6:55 PM ET
- Novel siRNA Therapeutic Cuts Liver Fat in MASLD, Early Trial ShowsMedPage Today, Nov 10, 5:07 PM ET(MedPage Today) -- One dose of a novel small interfering RNA (siRNA) therapy -- CIDEBsiRNA (also known as ALN-CIDEB) -- led to normal liver fat content and lower alanine aminotransferase (ALT) levels...
- More Women on Testosterone; Hormone Patch Updates; Drug-Induced Bone LossMedPage Today, Nov 10, 4:50 PM ET(MedPage Today) -- Testosterone use among females has risen since 2016 and is frequently prescribed without a documented diagnosis of hypoactive sexual desire disorder, the sole evidence-based...
- PepGen soars on promising early data for muscular dystrophy drugBioPharma Dive, Nov 10, 4:48 PM ETWhile from a small study, the findings suggest PepGen's therapy compares favorably to other RNA-based medicines in testing at Novartis and Dyne Therapeutics.
- FDA Approves First-in-Class Bayer Drug for Reducing the Risk of StrokeMedCity News, Nov 10, 3:59 PM ETBayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of the once-daily pill covers secondary stroke prevention in adults.
- Another Option for Rare Benign Soft-Tissue Tumor Wins FDA ApprovalMedPage Today, Nov 10, 3:22 PM ET(MedPage Today) -- The FDA approved the small-molecule inhibitor pimicotinib (Pimjetmi) for selected patients with symptomatic tenosynovial giant cell tumor (TGCT) and high surgical risk.
- Next-Gen Anticoagulant Lands FDA Nod for Secondary Stroke PreventionMedPage Today, Nov 10, 2:18 PM ET(MedPage Today) -- The FDA approved asundexian (Sunharbo) as the first factor XIa (FXIa) inhibitor for secondary stroke prevention, the agency announced on Monday.
- Cutaneous Sarcoidosis Could Soon Get an Effective TherapyMedPage Today, Nov 10, 1:15 PM ET(MedPage Today) -- ORLANDO -- Patients with cutaneous sarcoidosis -- a condition with no very effective therapy -- saw dramatic improvement with the dual-acting TYK2/JAK1 inhibitor brepocitinib...
- STAT+: Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drugSTAT, Nov 10, 1:04 PM ET
Global health
- John Kerry Tells COP31 the US Will Return to Climate Fight as Iran War Drives Surprise Dip in Fossil Fuel EmissionsHealth Policy Watch, Nov 10, 12:58 PM ETANTALYA, In a tale of America at a crossroads, former US Secretary of State John Kerry declared at COP31 on Tuesday that the country would soon return to a leadership role in the global response to...
- The Health Financing Crisis Demands Innovation: Lessons From Pooled Sputum Testing for TBHealth Policy Watch, Nov 10, 10:42 AM ETAt a laboratory in Cameroon, technicians receive sputum samples from people suspected of having tuberculosis (TB).
Also today
- HealthSpan Partners ups Surgery Partners offer to $6B after rival bidHealthcare Dive, Nov 10, 3:42 PM ETBon Secours' affiliate HealthSpan Partners is offering $300 million more for Surgery Partners as competition for the extensive surgical care network heats up with a rival bid.
- Surgery Partners' $6B deal, Q3 revenue slowdown: 8 things to knowBecker's ASC Review, Nov 10, 10:26 AM ETBrentwood, Tenn.-based Surgery Partners reported third-quarter revenue of $815.
- What independent physician practices can learn from private equityBecker's ASC Review, Nov 10, 5:34 PM ETPrivate equity's expansion into orthopedics has drawn its share of scrutiny over the past few years. Four surgeons say independent practices can learn from PE's playbook without selling to it.
- McLeod Health's operating income slips 9.7% in fiscal 2026: 5 things to knowBecker's Hospital Review, Nov 10, 5:33 PM ETFlorence, S.C.
- UC San Diego Health breaks ground on $434M outpatient pavilionBecker's Hospital Review, Nov 10, 5:23 PM ETUC San Diego Health broke ground Nov. 10 on the Gary and Mary West Outpatient Pavilion in La Jolla, Calif.
- Why near-miss safety events are a good thing for ASCsBecker's ASC Review, Nov 10, 5:06 PM ETA near miss is not a failure, it is proof the system worked. But that reframe only holds if leadership backs it up.
- Bioengineered Liver System Passes Safety Test in Phase I TrialMedPage Today, Nov 10, 4:53 PM ET(MedPage Today) -- A single-use bioengineered liver paired with an extracorporeal blood circuit that replicates key functions of a human liver was shown to be safe among patients with syndromes of...
- The CEO personality trait behind RTO mandates: StudyBecker's Hospital Review, Nov 10, 4:52 PM ETLeaders who score higher on narcissism are more likely to resist remote and hybrid work, according to a study published in the July issue of Organizational Behavior and Human Decision Processes.
- Oracle CEO on new Nashville HQ: ‘Giving caregivers more time to care’Becker's Hospital Review, Nov 10, 4:51 PM ETOracle broke ground Nov. 10 on its future global headquarters in Nashville, Tenn.
- GLP-1 Pill Shows Benefit in Sleep ApneaMedPage Today, Nov 10, 4:49 PM ET(MedPage Today) -- The oral GLP-1 receptor agonist orforglipron (Foundayo) improved sleep-disordered breathing in patients with moderate-to-severe obstructive sleep apnea and overweight or obesity,...
Actari is a free healthcare news and data terminal. Stories here are reported by the outlets named and link to them; Actari is not affiliated with the organizations in the news. AI reads are interpretation and can be wrong; nothing here is medical, legal or investment advice. Terms · Corrections and removal